(2,3,4,6-Tetra-O-benzyl-a-D-galactopyranosyl)methyl isothiocy-
anate (a-15a). Column chromatography with 7:1 cyclohexane-
AcOEt afforded a-15a (524 mg, 88%) as a yellow syrup; [a]D=
15.8 (c 1.3, CHCl3). 1H NMR: d = 7.40–7.20 (m, 20 H, Ph), 4.68
and 4.47 (2 d, 2 H, J = 12.0 Hz, PhCH2), 4.64 and 4.54 (2 d, 2
H, J = 11.8 Hz, PhCH2), 4.58 and 4.51 (2 d, 2 H, J = 11.0 Hz,
PhCH2), 4.57 (s, 2 H, PhCH2), 4.14–4.06 (m, 2 H, H-1, H-5),
4.00 (dd, 1 H, J3,4 = 4.0 Hz, J4,5 = 2.5 Hz, H-4), 3.91 (dd, 1 H,
J5,6a = 7.5 Hz, J6a,6b = 11.0 Hz, H-6a), 3.78–3.64 (m, 4 H, H-2,
H-3, H-6b, H-1¢a), 3.60 (dd, 1 H, J1,1¢b = 6.5 Hz, J1¢a,1¢b = 15 Hz,
H-1¢b). 13C NMR: d = 138.2, 138.0, 137.5, 137.4, 132.6, 128.5–
127.6 (20 C), 75.5, 74.9, 73.6, 73.4, 73.3, 73.2, 73.1, 72.9, 69.2,
66.3, 43.7. MALDI-TOF MS: 618.8 (M+ + Na). Anal. Calcd. for
C36H37NO5S (595.24): C, 72.58; N, 2.35; H, 6.26; S, 5.38. Found:
C, 72.39; N, 2.50; H, 6.02; S, 5.54.
3.10 (dd, 1 H, J1,1¢a = 3.0 Hz, J1¢a,1¢b = 15.0 Hz, H-1¢a), 2.97 (dd,
1 H, J1,1¢b = 5.0 Hz, H-1¢b), 2.87 (ddd, 1 H, H-1). 13C NMR: d =
138.2, 138.0, 137.8, 137.5, 133.0, 128.6–127.6 (20 C), 86.8, 79.2,
78.1, 77.3, 76.8, 75.6, 75.2, 75.1, 73.6, 68.8, 46.1. MALDI-TOF
MS: 634.9 (M+ + K). Anal. Calcd. for C36H37NO5S (595.24): C,
72.58; N, 2.35; H, 6.26; S, 5.38. Found: C, 72.37; N, 2.54; H, 6.42;
S, 5.09.
(2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl)methyl isothiocy-
anate (a-15c). Column chromatography (from 9:1 to 5:1
cyclohexane-AcOEt) afforded first a-15c (149 mg, 25%) and then
b-15c (298 mg, 50%). a-15c: [a]D= 59.5 (c 0.8, CHCl3). 1H NMR
(C6D6): d = 7.40–7.00 (m, 20 H, Ph), 4.78 and 4.59 (2 d, 2 H,
J = 11.5 Hz, PhCH2), 4.71 (s, 2 H, PhCH2), 4.45 and 4.30 (2 d, 2
H, J = 12.0 Hz, PhCH2), 4.20 and 4.12 (2 d, 2 H, J = 11.8 Hz,
PhCH2), 3.84 (ddd, 1 H, J1,2 = 5.5 Hz, J1,1¢a = 10.5 Hz, J1,1¢b
=
4.0 Hz, H-1), 3.74 (dd, 1 H, J3,4 = 8.5 Hz, J4,5 = 9.5 Hz, H-4), 3.70
(dd, 1 H, J5,6a = 2.5 Hz, J6a,6b = 10.5 Hz, H-6a), 3.67 (dd, 1 H,
J5,6b = 3.0 Hz, H-6b), 3,43 (dd, 1 H, J2,3 = 9.0 Hz, H-2), 3.38 (dd,
1 H, H-3), 3.32 (ddd, 1 H, H-5), 3.20 (dd, 1 H, J1¢a,1¢b = 15.0 Hz,
H-1¢a), 3.00 (dd, 1 H, H-1¢b). 13C NMR: d = 138.2, 137.9, 137.8,
137.4, 134.0, 128.6–127.7 (20 C), 81.6, 78.1, 77.3, 75.2, 74.8, 73.7,
73.6, 72.6, 72.3, 68.2, 42.0. MALDI-TOF MS: 618.8 (M+ + Na).
Anal. Calcd. for C36H37NO5S (595.24): C, 72.58; N, 2.35; H, 6.26;
S, 5.38. Found: C, 72.39; N, 2.17; H, 6.41; S, 5.54.
(2,3,4,6-Tetra-O-benzyl-b-D-mannopyranosyl)methyl isothiocy-
anate (b-15b). Column chromatography with 6:1 cyclohexane-
AcOEt afforded b-15b (482 mg, 81%) as a yellow syrup; [a]D=
-36.0 (c 1.0, CHCl3). 1H NMR: d = 7.50–7.10 (m, 20 H, Ph), 5.10
and 4.68 (2 d, 2 H, J = 11.5 Hz, PhCH2), 4.91 and 4.48 (2 d, 2
H, J = 11.0 Hz, PhCH2), 4.84 and 4.79 (2 d, 2 H, J = 11.8 Hz,
PhCH2), 4.65 and 4.56 (2 d, 2 H, J = 12.0 Hz, PhCH2), 3.98 (dd,
1 H, J3,4 = 9.0 Hz, J4,5 = 9.0 Hz, H-4), 3.92 (dd, 1 H, J1,2 = 1.0 Hz,
J2,3 = 3.5 Hz, H-2), 3.80–3.70 (m, 3 H, H-1, 2 H-6), 3.68 (dd, 1 H,
H-3), 3.55 (d, 2 H, J1¢a,1¢b = 12.5 Hz, 2H-1¢), 3.50 (ddd, 1 H, J5,6a
=
Na-(9-Fluorenylmethoxycarbonyloxy)-b-amino-L-alanine tert-
2.5 Hz, J5,6b = 5.5 Hz, H-5). 13C NMR: d = 138.0, 137.9, 137.8,
137.6, 132.0, 128.5–127.5 (20 C), 84.4, 79.8, 76.0, 75.2, 74.8, 74.5,
73.4, 73.0, 72.7, 69.1, 45.0. MALDI-TOF MS: 618.3 (M+ + Na).
Anal. Calcd. for C36H37NO5S (595.24): C, 72.58; N, 2.35; H, 6.26;
S, 5.38. Found: C, 72.40; N, 2.49; H, 6.52; S, 5.12.
butyl ester (6). To
a
cooled (0 ◦C), stirred mixture
of
ester
commercially
hydrochloride
available
(800
L-asparagine
mg, 3.56 mmol),
tert-butyl
N-(9-
fluorenylmethoxycarbonyloxy)succinimide (1.80 g, 5.34 mmol),
and THF-H2O (20 mL-12 mL) saturated NaHCO3 aqueous
solution was added till basic pH was reached. The resulting
mixture was warmed to room temperature, stirred for 14 h, cooled
to 0 ◦C, neutralized with saturated NH4Cl aqueous solution,
diluted with AcOEt (100 mL), and washed with brine (2 ¥ 20 mL).
The organic phase was dried (Na2SO4), concentrated, and
eluted from a column of silica gel with 1:2 cyclohexane-AcOEt
(containing 10% of CH2Cl2) to give Fmoc-Asn-Ot-Bu 1620 (1.31 g,
(2,3,4,6-Tetra-O-benzyl-a-D-mannopyranosyl)methyl isothiocy-
anate (a-15b). Column chromatography with 5:1 cyclohexane-
AcOEt afforded a-15b (494 mg, 83%) as a yellow syrup; [a]D=
29.7 (c 1.0, CHCl3). 1H NMR: d = 7.40–7.10 (m, 20 H, Ph), 4.58
and 4.42 (2 d, 2 H, J = 12.0 Hz, PhCH2), 4.53 and 4.48 (2 d, 2
H, J = 11.0 Hz, PhCH2), 4.50 and 4.46 (2 d, 2 H, J = 11.5 Hz,
PhCH2), 4.44 and 4.38 (2 d, 2 H, J = 11.8 Hz, PhCH2), 4.15 (ddd,
1 H, J4,5 = 8.0 Hz, J5,6a = 3.0 Hz, J5,6b = 5.5 Hz, H-5), 4.02 (ddd, 1
H, J1,2 = 3.0 Hz, J1,1¢a = 5.5 Hz, J1,1¢b = 9.0 Hz, H-1), 3.83 (dd, 1 H,
J6a,6b = 10.5 Hz, H-6a), 3.82 (dd, 1 H, J3,4 = 8.0 Hz, H-4), 3.78–3.70
(m, 4 H, H-2, H-3, 2H-1¢), 3.68 (dd, 1 H, H-6b). 13C NMR: d =
138.1, 137.9, 137.7, 137.4, 132.4, 128.5–127.6 (20 C), 74.6, 73.9,
73.4, 73.3, 73.0, 72.6, 71.8, 71.2, 68.6, 67.8, 46.6. MALDI-TOF
MS: 596.5 (M+ + H). Anal. Calcd. for C36H37NO5S (595.24): C,
72.58; N, 2.35; H, 6.26; S, 5.38. Found: C, 72.79; N, 2.59; H, 6.45;
S, 5.22.
◦
1
90%) as a white solid (mp 136–138 C, from MeCN). H NMR:
d = 7.81–7.78 (m, 2 H, Ar), 7.68–7.60 (m, 2 H, Ar), 7.45–7.20
(m, 4 H, Ar), 6.00 (d, 1 H, J2,NH = 8.5 Hz, NaH), 5.69 (bs, 1 H,
NH), 5.40 (bs, 1 H, NH), 4.50 (ddd, 1 H, J2,3a = 5.5 Hz, J2,3b
=
4.5 Hz, H-2), 4.42–4.32 (m, 2 H, FmocCH2), 4.30.4.20 (m, 1 H,
FmocCH), 2.96 (dd, 1 H, J3a,3b = 16.0 Hz, H-3a), 2.78 (dd, 1 H,
H-3b), 1.42 (s, 9 H, t-Bu).
To a stirred solution of 16 (500 mg, 1.22 mmol) in H2O-MeCN
(6 mL-6 mL) were added I,I-bis(trifluoroacetoxy)iodobenzene
(682 mg, 1.59 mmol) and pyridine (197 mL, 2.44 mmol). The
resulting mixture was stirred at room temperature for 2.5 h, then
diluted with AcOEt (80 mL), and washed with brine (2 ¥ 10 mL).
The organic phase was dried (Na2SO4), concentrated, and eluted
from a column of silica gel with 19:1 CH2Cl2-MeOH to afford 6
(2,3,4,6-Tetra-O-benzyl-b-D-glucopyranosyl)methyl isothiocy-
anate (b-15c). Column chromatography (from 9:1 to 5:1
cyclohexane-AcOEt) afforded first a-15c (149 mg, 25%) and then
b-15c (298 mg, 50%). b-15c: [a]D= -46.1 (c 1.1, CHCl3). 1H NMR
(C6D6): d = 7.40–7.00 (m, 20 H, Ph), 4.82 and 4.72 (2 d, 2 H, J =
11.5 Hz, PhCH2), 4.76 and 4.55 (2 d, 2 H, J = 10.5 Hz, PhCH2),
4.72 and 4.33 (2 d, 2 H, J = 11.0 Hz, PhCH2), 4.48 and 4.37 (2 d,
1
(401 mg, 86%) as a white foam; [a]D= -19.9 (c 1.0, MeOH). H
NMR: d = 7.80–7.70 (m, 2 H, Ar), 7.65–7.55 (m, 2 H, Ar), 7.42–
7.25 (m, 4 H, Ar), 5.58 (d, 1 H, J2,NH = 8.5 Hz, NaH), 4.41 (d, 2
2 H, J = 12.0 Hz, PhCH2), 3.64 (dd, 1 H, J5,6a = 4.5 Hz, J6a,6b
=
H, J = 8.0 Hz, FmocCH2), 4.28 (bddd, 1 H, J2,3a = 4.5 Hz, J2,3b =
9.5 Hz, H-6a), 3.62 (dd, 1 H, J3,4 = 9.0 Hz, J4,5 = 8.5 Hz, H-4),
3.59 (dd, 1 H, J5,6b¢ = 2.5 Hz, H-6b), 3.47 (dd, 1 H, J2,3 = 9.0 Hz,
H-3), 3.26 (dd, 1 H, J1,2 = 9.5 Hz, H-2), 3.18 (ddd, 1 H, H-5),
5.5 Hz, H-2), 4.22 (t, 1 H, J = 8.0 Hz, FmocCH), 3.10 (dd, 1 H,
J3a,3b = 12.5 Hz, H-3a), 3.04 (dd, 1 H, H-3b), 1.90 (bs, 2 H, NH2),
1.42 (s, 9 H, t-Bu). 13C NMR: d = 169.9, 156.3, 143.7 (2 C), 141.2
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 3319–3330 | 3327
©